Active

Advent Life Sciences

Investor type

VC

Founded

2005

AUM

$92 000 M

Location

London, England, United Kingdom

Investment Ticket

$1-5 m

Investment Stage

Seed Series B Series A

Region of investment

North America Europe
Investor profile last updated: 22 May, 2025

Profile

Advent Life Sciences is one of the leading trans-Atlantic venture investors focused on building innovative Life Sciences businesses in the UK, Europe and the USA. We are a highly experienced team with a long-standing track record of entrepreneurial and inve stment success through turning break-through science into approved medicines or medical products. We start and invest in early and mid-stage companies with a first-in-class or best-in-class approach. Our investments are focussed in new drug discovery - small molecules, biologics and new modalities - med tech, enabling technologies and vaccines.

Industry

Biotechnology Fashion/Beauty Healthcare Services Medical Devices Pharmaceuticals MedTech Life Sciences HealthTech Technology

Advent Life Sciences Funds

Name Type
Questionare
Industry
Questionare
Stage
Questionare
Region
Size AUM Launch date
Advent Life Sciences Fund I
Venture Capital (VC)
Healthcare Services
Medical Devices
MedTech
Technology
Pre-seed
Seed
North America
Europe
$5-10 m
$95 M
December 2010

Contacts

Name
Title
Email
avatar
Shahzad Malik General Partner
General Partner
s•••@•••
avatar
Raj Parekh General Partner
General Partner
-
Upgrade to see contacts
avatar
FafdAQjSz35NiboT FafdAQjSz35NiboT
FafdAQjSz35NiboT
avatar
FafdAQjSz35NiboT FafdAQjSz35NiboT
FafdAQjSz35NiboT
avatar
FafdAQjSz35NiboT FafdAQjSz35NiboT
FafdAQjSz35NiboT
Investment-team contacts for Advent Life Sciences — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Advent Life Sciences

Advent Life Sciences is a venture capital firm. It backs companies at Seed, Series B and Series A, writing tickets of $1-5 m.
Advent Life Sciences is located in London, England, United Kingdom.
Advent Life Sciences was founded in 2005.
Advent Life Sciences invests in companies and startups in Biotechnology, Fashion/Beauty, Healthcare Services, Medical Devices, Pharmaceuticals, MedTech, Life Sciences, HealthTech, Technology.
Advent Life Sciences invests in companies and startups in North America, Europe.
Advent Life Sciences invests in companies and startups at Seed, Series B, Series A.
Advent Life Sciences usually invests $1-5 m on average.
Advent Life Sciences has around $92 000m assets under management.
Advent Life Sciences last fund was created/launched in 2010-12-01
Advent Life Sciences can be reached through its website adventls.com, its LinkedIn page and its X account. Its general enquiries address is contact@adventls.com. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Advent Life Sciences — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Advent Life Sciences directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 22 May, 2025. Something out of date here? Report it — we re-run that firm within 48h and get back to you.